Up-to-date results on survival of patients with melanoma in Germany

The British Journal of Dermatology
Nora EisemannGEKID Survival Working Group

Abstract

Prior analyses of survival of patients with primary cutaneous malignant melanoma from Germany were based only on small populations and need to be updated. We give a detailed overview of relative 5-year survival by sex, age group, histology, tumour stage and body site, and of time trends in a population of 33 million (40% of Germany), and compare survival in the federal states. Conventional and model-based period analysis using the Ederer II method was applied to patients with melanoma diagnosed during 1997-2006 in Germany to assess 5-year relative survival (RS) rates and time trends. In total, 37,155 melanoma cases were included. Overall age-adjusted 5-year RS for the time period 2002-2006 was 91·9% for women and 87·0% for men. Survival differences by age group, histology, tumour stage and body site were found. No significant overall trend (2002-2006) was seen either in women or in men. Differences in survival between federal states were small; no clear pattern was seen. Based on the most recent and high-quality data from population-based cancer registries a comprehensive picture on melanoma survival in Germany was given. Survival from cutaneous malignant melanoma was high compared with other cancer sites and did not change dur...Continue Reading

References

Sep 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H K KohT B Fitzpatrick
Nov 15, 1995·Cancer·D E Henson, L A Ries
Oct 10, 1998·International Journal of Cancer. Journal International Du Cancer·F LeviS Franceschi
Mar 23, 1999·Archives of Dermatology·M A RichardP Chemaly
Oct 24, 2000·Clinical and Experimental Dermatology·R M MacKie
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hermann Brenner, Timo Hakulinen
Mar 28, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H BrennerT Hakulinen
Sep 21, 2002·Lancet·Rona M MacKieUNKNOWN Scottish Melanoma Group
Dec 18, 2002·Der Radiologe·T Rüdiger, H K Müller-Hermelink
Jan 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H BrennerT Hakulinen
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Isabella CorazziariRiccardo Capocaccia
Jul 15, 2006·American Journal of Epidemiology·Hermann Brenner, Timo Hakulinen
Dec 21, 2006·Archives of Dermatology·Wendy LiuJohn W Kelly
Nov 3, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E de VriesJ-W W Coebergh
Feb 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Henrike E Karim-KosJan Willem W Coebergh
May 6, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A GondosUNKNOWN EUNICE Survival Working Group
Dec 11, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GondosUNKNOWN EUNICE Survival Working Group
Feb 17, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Franco BerrinoUNKNOWN EUROCARE Working Group
Mar 14, 2009·Methods of Information in Medicine·Bernd HolleczekH Brenner
May 27, 2009·World Journal of Gastroenterology : WJG·Shan-Rong CaiShu Zheng
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Feb 2, 2011·International Journal of Surgery·Mohammad HowladerMohamed Rela
May 21, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E HiripiUNKNOWN GEKID Cancer Survival Working Group
Nov 15, 2011·Journal of the American Academy of Dermatology·Eckhard W BreitbartAlexander Katalinic
Feb 22, 2012·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Martin Radespiel-TrögerMatthias Fenner

❮ Previous
Next ❯

Citations

Dec 21, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·N EisemannA Katalinic
Dec 21, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·M Blettner, S Ludwig
Oct 19, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·F A Bahmer, J A Bahmer
Oct 12, 2012·Amino Acids·Nadine TandlerJens Pietzsch
Apr 22, 2015·International Journal of Oncology·Christian OstheimerDirk Vordermark
Apr 5, 2013·The British Journal of Dermatology·C HolterhuesE de Vries
Feb 1, 2015·BMC Cancer·Peter D BaadeJoanne F Aitken
Oct 7, 2016·Journal of the American Academy of Dermatology·Alicia BrunssenAlexander Katalinic
Aug 26, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Nora EisemannAlexander Katalinic
Apr 2, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·P KaskelM Kron
Jul 19, 2018·Melanoma Research·Alicia BrunssenUNKNOWN GEKID Cancer Survival Working Group
Mar 19, 2016·Melanoma Research·Lisa E PaddockMarianne Berwick
Apr 25, 2019·The Australasian Journal of Dermatology·Berenice Monserratt Pérez-AldreteAlberto Tlacuilo-Parra
Oct 21, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Wen-Qing LiAbrar A Qureshi
Jan 21, 2020·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Frances Anne McHughPatrick Schweder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Surgical Clinics of North America
Renee A Desmond, Seng-jaw Soong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
David C WhitemanAdèle C Green
The Journal of Dermatology
Iris ZalaudekGiuseppe Argenziano
© 2021 Meta ULC. All rights reserved